VBI Vaccines Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
23 Pages - GLDATA56316
$250.00

Summary

VBI Vaccines (VBI) is a biotechnology company that discovers and develops new vaccines for the treatment of infectious diseases. The company offers various technologies such as eVLP Platform, Thermostable Platform, ottawa research facility and scientific literature. It develops products for hepatitis A, hepatitis B, and intestinal infectious diseases. VBI’s thermostat IM program includes thermostatable IM Flu, thermostatable IM measles and undisclosed target products. It offers various vaccine programs such as Prophylactic Cytomegalovirus (CMV) Vaccine and Therapeutic Hepatitis C (HCV) Vaccine. The company operates through its research facilities in Ottawa, Canada. VBI is headquartered in Cambridge, Massachusetts, the US.

VBI Vaccines Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 10
Variation Biotechnologies Raises US$2.2 Million In Venture Financing 11
Variation Biotechnologies Secures An Additional US$3.5 Million In Venture Financing 12
Partnerships 14
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 14
VBI Vaccines Enters into Research Agreement with Sanofi Pasteur 15
Equity Offering 16
VBI Vaccines Raises USD6.3 million in Private Placement Shares 16
Acquisition 17
SciVac Therapeutics Acquires VBI Vaccines 17
VBI Vaccines Acquires Epixis 19
VBI Vaccines Inc. - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Key Facts 1
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc., Deals By Therapy Area, 2010 to YTD 2016 8
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 10
Variation Biotechnologies Raises US$2.2 Million In Venture Financing 11
Variation Biotechnologies Secures An Additional US$3.5 Million In Venture Financing 12
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 14
VBI Vaccines Enters into Research Agreement with Sanofi Pasteur 15
VBI Vaccines Raises USD6.3 million in Private Placement Shares 16
SciVac Therapeutics Acquires VBI Vaccines 17
VBI Vaccines Acquires Epixis 19
VBI Vaccines Inc., Key Competitors 20
VBI Vaccines Inc., Key Employees 21
VBI Vaccines Inc., Other Locations 22

List of Figures
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838